Literature DB >> 11051619

The ECO.SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens--interim report.

G Kahlmeter1.   

Abstract

The ECO.SENS Project is the first international survey to investigate the prevalence and susceptibility of pathogens causing community-acquired, uncomplicated urinary tract infections (UTIs) in women. At 240 centres in 17 countries, female patients presenting with symptoms of uncomplicated UTIs were asked to provide a urine sample for testing for the presence of leucocytes and bacteria. The bacteria were identified and their susceptibility to 12 antibiotics commonly used in the treatment of UTIs was determined. The objective of the survey was to collect 5000 urine samples to obtain approximately 3500 isolates of defined uropathogens. This interim report includes the results from 1960 urine samples, 75% of which contained a uropathogen. Escherichia coli accounted for the majority (80%) of uropathogens isolated in all 17 countries. The rates of resistance among E. coli strains were: ampicillin and sulphamethoxazole, 30%; trimethoprim alone or with sulphamethoxazole, 15%; nalidixic acid, 6%; ciprofloxacin, 3%; amoxycillin-clavulanic acid, mecillinam, cefadroxil, nitrofurantoin and fosfomycin, < or =2%. The use of ampicillin, sulphonamides and trimethoprim alone or with sulphamethoxazole needs to be reconsidered. The seemingly rapid increase in quinolone resistance among community-acquired E. coli in some of the countries gives cause for concern.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11051619

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  22 in total

Review 1.  Uncomplicated urinary tract infection in women. Current practice and the effect of antibiotic resistance on empiric treatment.

Authors:  Lindsay Nicolle; Peter A M Anderson; John Conly; Thomas C Mainprize; Jamie Meuser; J Curtis Nickel; Vyta M Senikas; George G Zhanel
Journal:  Can Fam Physician       Date:  2006-05       Impact factor: 3.275

2.  Healthcare-associated urinary tract infections in hospitalized urological patients--a global perspective: results from the GPIU studies 2003-2010.

Authors:  Mete Cek; Zafer Tandoğdu; Florian Wagenlehner; Peter Tenke; Kurt Naber; Truls Erik Bjerklund-Johansen
Journal:  World J Urol       Date:  2014-01-23       Impact factor: 4.226

3.  Adaptation of Escherichia coli traversing from the faecal environment to the urinary tract.

Authors:  Karen L Nielsen; Marc Stegger; Paul A Godfrey; Michael Feldgarden; Paal S Andersen; Niels Frimodt-Møller
Journal:  Int J Med Microbiol       Date:  2016-11-04       Impact factor: 3.473

4.  Biological costs and mechanisms of fosfomycin resistance in Escherichia coli.

Authors:  Annika I Nilsson; Otto G Berg; Olle Aspevall; Gunnar Kahlmeter; Dan I Andersson
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

5.  High-throughput identification of chemical inhibitors of E. coli Group 2 capsule biogenesis as anti-virulence agents.

Authors:  Carlos C Goller; Patrick C Seed
Journal:  PLoS One       Date:  2010-07-19       Impact factor: 3.240

6.  Dose escalation study of the safety, tolerability, and pharmacokinetics of nemonoxacin (TG-873870), a novel potent broad-spectrum nonfluorinated quinolone, in healthy volunteers.

Authors:  Luke Lin; Li-Wen Chang; Cheng-Yuan Tsai; Ching-Hung Hsu; David T Chung; William S Aronstein; Funmi Ajayi; Barbara Kuzmak; Robert A Lyon
Journal:  Antimicrob Agents Chemother       Date:  2009-11-02       Impact factor: 5.191

7.  Thirteen years of antibiotic susceptibility surveillance of Pseudomonas aeruginosa from intensive care units and urology services in the Netherlands.

Authors:  P D Croughs; B Li; J A A Hoogkamp-Korstanje; E Stobberingh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09-08       Impact factor: 3.267

8.  Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections.

Authors:  Patricia Komp Lindgren; Asa Karlsson; Diarmaid Hughes
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

Review 9.  Evaluation of antimicrobial susceptibility of Enterobacteriaceae causing urinary tract infections in Africa.

Authors:  Giannoula S Tansarli; Stavros Athanasiou; Matthew E Falagas
Journal:  Antimicrob Agents Chemother       Date:  2013-05-20       Impact factor: 5.191

10.  In vitro evaluation of a new treatment for urinary tract infections caused by nitrate-reducing bacteria.

Authors:  S Carlsson; M Govoni; N P Wiklund; E Weitzberg; J O Lundberg
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.